Hironori Kuga

Dr. Hironori Kuga


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
TNTomohiro Nakao
Tomohiro Nakao
KMKeitaro Murayama
Keitaro Murayama
STSho Takahashi
Sho Takahashi
MKMami Kayama
Mami Kayama
Daisuke NishiDaisuke Nishi
Daisuke Nishi
HKHironori Kuga
Hironori Kuga
The number of people with coronavirus disease (COVID-19) has been increasing worldwide. Anxiety about potential infection, fear of severe illness, death, economic problems, and loneliness and isolation brought on by social distancing are increasingly being experienced by people. Therefore, it is imperative to address and improve such mental health-related problems during COVID-19. We aimed to investigate the current mental health care and psychological intervention statuses related to COVID-19 in Japan. In a questionnaire survey, 55 of 69 (80%) mental health and welfare centers and 194 of 931 (21%) psychiatric institutions across Japan responded. COVID-19 patients, their family members, and the general public often consulted the mental health and welfare institutions through telephone. The questionnaire included various information of mental health difficulties related to COVID-19 such as the numbers and contents of the consultations, and the type of the interventions. The contents of consultation included psychological symptoms (anxiety, depression, insomnia, and alcohol problems) and psychosocial problems (interpersonal problems, prejudice, and discrimination). Overall, 9% of mental health and welfare centers provided psychological first aid as psychological intervention and 28% of consultations involved cases requiring urgent care. In Japan, consultations about COVID-19-related mental health problems occurred mainly in mental health and welfare centers. There is urgent need to establish a system that enables mental health triage and brief psychological interventions that are feasible in the centers.

8 June 2023 in Psychiatry and Clinical Neurosciences Reports
Verified
Journal Article
Open access
MKMasahide Koda
Masahide Koda
THToru Horinouchi
Toru Horinouchi
NONozomu Oya
Nozomu Oya
MAMorio Aki
Morio Aki
AIAkihisa Iriki
Akihisa Iriki
TNTomohiro Nakao
Tomohiro Nakao
There is insufficient research on the usefulness of psychological interventions, such as psychological first aid (PFA), during outbreaks. We searched for and critically appraised systematic reviews that examined the effectiveness of PFA during infectious disease outbreaks, such as the novel coronavirus disease (COVID‐19). Systematic reviews that examined the efficacy of PFA in the severe acute respiratory syndrome, Middle East respiratory syndrome coronavirus, Ebola virus disease, and COVID‐19 outbreaks were searched through PubMed on February 19, 2021. The three included systematic reviews were critically appraised and assessed using AMSTAR‐2. One review's overall confidence in its findings was evaluated as “high,” which suggested that PFA training had a favorable effect on healthcare personnel. Furthermore, the review also demonstrated that PFA was commonly used during outbreaks and could be delivered through multiple methods, such as a phone or video call. Although it was anticipated that PFA would improve subjective well‐being, reports showed no evidence of reduced depression or insomnia. Future studies should examine additional numbers of PFA recipients and conduct quasi‐experimental studies to better understand the effectiveness of PFA. Evidence on its effectiveness in infectious disease outbreaks is still lacking, along with research and evaluation methods. Quasi‐experimental studies, such as comparisons with other psychological interventions, are required to better understand the effectiveness of PFA.

2 December 2024 in Psychiatry and Clinical Neurosciences Reports
Verified
Journal Article
Open access
NTNaoki Takamatsu
Naoki Takamatsu
MNMisuzu Nakashima
Misuzu Nakashima
KMKei Matsuura
Kei Matsuura
IUIkue Umemoto
Ikue Umemoto
MIMasaya Ito
Masaya Ito
HKHironori Kuga
Hironori Kuga
Background: Attention‐deficit/hyperactivity disorder (ADHD) symptoms, including executive function, emotional regulation, and motivation, can persist into adulthood and are often associated with mental illnesses. Cognitive behavioral therapy (CBT) may help ADHD adults in Japan, but the lack of studies and the variability in group CBT approaches make its effects unclear. Japan lacks unified CBT programs and adult ADHD guidelines, making it difficult to implement international individual CBT recommendations due to cultural differences. This study will assess the feasibility of a novel CBT program for Japanese adult ADHD patients.Methods: This feasibility study will be open, nonrandomized, single‐arm, multicenter study. Twelve ADHD patients aged 20–65 years who are currently receiving treatment will be included based on Conners' Adult ADHD Rating Scale (CAARS) clinical severity threshold. An intervention phase of 12–16 weeks and a 12‐week follow‐up will total 24–28 weeks for all participants. The intervention will use a new CBT program tailored to individual assessments.Results: The primary objective is to determine feasibility using dropout rates, adverse events, and CAARS score changes between Weeks 1 and 16. The secondary outcomes will assess long‐term effects of treatment beyond the intervention period and provide descriptive statistics on sex, depression, quality of life, and autistic scores in relation to the intervention outcomes. The full analysis set and per protocol set will be used for statistical analysis.Conclusions: This study is essential for the development of CBT interventions in accordance with Japan's healthcare system that are tailored to the unique needs of its population.

14 February 2019 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
YNYukako Nakagami
Yukako Nakagami
GSGenichi Sugihara
Genichi Sugihara
HKHironori Kuga
Hironori Kuga
HTHidehiko Takahashi
Hidehiko Takahashi
TMToshiya Murai
Toshiya Murai

1 September 2025 in Clinical Psychology & Psychotherapy
Verified
Journal Article
Closed access
SSSo Sugita
So Sugita
MIMasaya Ito
Masaya Ito
HFHiroko Fujisato
Hiroko Fujisato
AKAyako Kanie
Ayako Kanie
SNShun Nakajima
Shun Nakajima
HKHironori Kuga
Hironori Kuga

19 March 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
MKMACHIKO KAJIWARA
MACHIKO KAJIWARA
NKNoriko Kato
Noriko Kato
MNMotohiro Nishiuchi
Motohiro Nishiuchi
HFHiroko Fujisato
Hiroko Fujisato
KKKyousuke Kaneko
Kyousuke Kaneko
MIMasaya Ito
Masaya Ito
The group format of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) shows promise as a efficient method for delivering established and effective psychological treatments for emotional disorders. The implementation of psychological treatment in a group format varies according to a country’s local circumstances, policies, and culture. To date, there are no comprehensive reviews of aspects related to settings, participants, providers, and interventions for applying the UP in a group context. Therefore, we have prepared a scoping review protocol to clarify the fields, participant characteristics, intervention structures, and therapist training methods related to group-format UP, aiming to facilitate its implementation across diverse regions and contexts. Based on this protocol, the scoping review will follow the Joanna Institute guidelines and PRISMA statement extensions for scoping reviews. The review will include studies of the group format of UP that describe symptoms of emotional disorders in adults. The following databases will be searched: PubMed, MEDLINE, Web of Science, PsycINFO, and ClinicalTrials.gov. The selected data will be organized according to four predefined research questions. This scoping review will provide suggestions to promote the application and implementation of the UP in a group format and contribute to disseminating evidence-based psychological treatment.